Cargando…
Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study
Patients with severe COVID-19 experience cytokine storm, an uncontrolled upregulation of pro-inflammatory cytokines, which if unresolved leads to acute respiratory distress syndrome (ARDS), organ damage, and death. Treatments with mesenchymal stromal cells (MSC) [Viswanathan S, Shi Y, Galipeau J, et...
Autores principales: | Grumet, Martin, Sherman, Jason, Dorf, Barry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672850/ https://www.ncbi.nlm.nih.gov/pubmed/36181766 http://dx.doi.org/10.1093/stcltm/szac067 |
Ejemplares similares
-
Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range?
por: Kabat, Maciej, et al.
Publicado: (2019) -
Umbilical Cord‐Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial
por: Matas, Jose, et al.
Publicado: (2018) -
COVID-19 on the riverbank
por: Lodge, Andrew
Publicado: (2022) -
COVID-19 lockdown revisionism
por: Murdoch, Blake, et al.
Publicado: (2023) -
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada
por: Mosby, Ian, et al.
Publicado: (2021)